N<sup>6</sup>-methyladenosine RNA modification suppresses antiviral innate sensing pathways via reshaping double-stranded RNA.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33707441.
- Also identified by DOI 10.1038/s41467-021-21904-y and PMC identifier 7952553.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Double-stranded RNA (dsRNA) is a virus-encoded signature capable of triggering intracellular Rig-like receptors (RLR) to activate antiviral signaling, but whether intercellular dsRNA structural reshaping mediated by the N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) modification modulates this process remains largely unknown. Here, we show that, in response to infection by the RNA virus Vesicular Stomatitis Virus (VSV), the m<sup>6</sup>A methyltransferase METTL3 translocates into the cytoplasm to increase m<sup>6</sup>A modification on virus-derived transcripts and decrease viral dsRNA formation, thereby reducing virus-sensing efficacy by RLRs such as RIG-I and MDA5 and dampening antiviral immune signaling. Meanwhile, the genetic ablation of METTL3 in monocyte or hepatocyte causes enhanced type I IFN expression and accelerates VSV clearance. Our findings thus implicate METTL3-mediated m<sup>6</sup>A RNA modification on viral RNAs as a negative regulator for innate sensing pathways of dsRNA, and also hint METTL3 as a potential therapeutic target for the modulation of anti-viral immunity.
Medical subject headings
- Adenosine
- Methyltransferases
- RNA, Double-Stranded
- RNA, Viral
- Vesicular stomatitis Indiana virus